Part of The Mesothelioma Center. Contact Us
Mesothelioma-Line.com.
Journal Articles on Mesothelioma: Cancer Information for Patients and Families

Journal Articles on Mesothelioma: January, 2005

January 26th, 2005. Pathogenesis of malignant pleural mesothelioma

Moreover, asbestos is still used in developing countries. The implication of other risk factors, especially SV40, supports a need for further research into MPM.
Posted in Causation, Full Archive, Occupational Asbestos Exposure, Pleural, SV40, Type of Mesothelioma: | No Comments »

January 25th, 2005. The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050

The eventual death rate will depend on the background level and any residual asbestos exposure. Between 1968 and 2050, there will have been approximately 90,000 deaths from mesothelioma in Great Britain, 65,000 of which will occur after 2001.
Posted in Diagnosis & Differentiation, Full Archive | No Comments »

January 25th, 2005. Radiofrequency Ablation of Thoracic Lesions: Part 2, Initial Clinical Experience Technical and Multidisciplinary Considerations in 30 Patients

Numerous other thoracic interventional radiology procedures are beneficial to assist the radiofrequency ablation. A multidisciplinary approach offers valuable expertise for patient care.
Posted in Determining Efficacy, Full Archive, Radiofrequency Ablation, Treatment | No Comments »

January 24th, 2005. Raltitrexed-Oxaliplatin combination chemotherapy is inactive as second-line treatment for malignant pleural mesothelioma patients

85, range: 7-20), while median overall survival was just 14 weeks (average: 21. 69, range: 9-66+).
Posted in Full Archive, Oxaliplatin (Eloxatin), Raltitrexed (Tomudex), Treatment | No Comments »
Goldberg, Persky & White, P.C. Mesothelioma Lawyers